Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption

Background Teduglutide, a glucagon-like peptide 2 analog, has demonstrated efficacy in treating adult patients with short bowel syndrome (SBS) and dependence on parenteral nutrition (PN), but its role in chronic malabsorptive states that do not necessitate PN remains uncertain.